Charles River Laboratories International, Inc.
CRL · NYSE
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $55,556 | $52,693 | $25,878 | -$213,747 |
| Dep. & Amort. | $85,164 | $119,507 | $120,364 | $102,104 |
| Deferred Tax | $25,908 | -$21,989 | -$19,041 | -$41,440 |
| Stock-Based Comp. | $23,267 | $17,049 | $13,135 | $17,235 |
| Change in WC | -$5,145 | $11,167 | $1,287 | -$42,396 |
| Other Non-Cash | $29,076 | $26,176 | $30,074 | $337,606 |
| Operating Cash Flow | $213,826 | $204,603 | $171,697 | $159,362 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$35,580 | -$35,298 | -$59,324 | -$75,616 |
| Net Acquisitions | -$17,441 | $0 | $17,441 | $0 |
| Inv. Purchases | -$4,454 | -$2,788 | -$5,302 | -$7,612 |
| Inv. Sales/Matur. | $3,531 | $504 | $1,602 | $2,217 |
| Other Inv. Act. | $20,248 | $243 | $104 | $4,907 |
| Investing Cash Flow | -$33,696 | -$37,339 | -$45,479 | -$76,104 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$146,296 | -$191,290 | $266,947 | -$71,981 |
| Stock Issued | $2 | $0 | $0 | $0 |
| Stock Repurch. | -$93 | -$7,352 | -$353,132 | -$124 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6,229 | -$28,279 | -$19,140 | -$3,774 |
| Financing Cash Flow | -$152,616 | -$226,921 | -$105,325 | -$75,879 |
| Forex Effect | -$3,034 | $12,669 | $5,265 | -$13,449 |
| Net Chg. in Cash | $24,480 | -$46,988 | $26,158 | -$6,070 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $184,740 | $231,728 | $205,570 | $211,640 |
| End Cash | $209,220 | $184,740 | $231,728 | $205,570 |
| Free Cash Flow | $178,246 | $169,305 | $112,373 | $83,746 |